"Narrative Summit" Releases 2025 Recommendations to Cement Egypt's Position as a Global Tourism Destination    Egypt, S.Arabia step up trade ties through coordination council talks    Egypt reviews progress on $200m World Bank-funded waste management hub    Egypt urges Israel to accept Gaza deal amid intensifying fighting    Egypt, ADIB explore strategic partnership in digital healthcare, investment    SCZONE, Tokyo Metropolitan Government sign MoU on green hydrogen cooperation    Egypt welcomes international efforts for peace in Ukraine    Al-Sisi, Macron reaffirm strategic partnership, coordinate on Gaza crisis    Contact Reports Strong 1H-2025 on Financing, Insurance Gains    Egypt, India's BDR Group in talks to establish biologics, cancer drug facility    AUC graduates first cohort of film industry business certificate    Egyptian pound down vs. US dollar at Monday's close – CBE    Egypt's FM, Palestinian PM visit Rafah crossing to review Gaza aid    Egypt prepares unified stance ahead of COP30 in Brazil    Egypt recovers collection of ancient artefacts from Netherlands    Egypt harvests 315,000 cubic metres of rainwater in Sinai as part of flash flood protection measures    Egypt, Namibia explore closer pharmaceutical cooperation    Fitch Ratings: ASEAN Islamic finance set to surpass $1t by 2026-end    Renowned Egyptian novelist Sonallah Ibrahim dies at 88    Egyptian, Ugandan Presidents open business forum to boost trade    Al-Sisi says any party thinking Egypt will neglect water rights is 'completely mistaken'    Egypt's Sisi warns against unilateral Nile measures, reaffirms Egypt's water security stance    Egypt's Sisi, Uganda's Museveni discuss boosting ties    Egypt, Huawei explore healthcare digital transformation cooperation    Egypt's Sisi, Sudan's Idris discuss strategic ties, stability    Egypt to inaugurate Grand Egyptian Museum on 1 November    Greco-Roman rock-cut tombs unearthed in Egypt's Aswan    Egypt reveals heritage e-training portal    Sisi launches new support initiative for families of war, terrorism victims    Egypt expands e-ticketing to 110 heritage sites, adds self-service kiosks at Saqqara    Palm Hills Squash Open debuts with 48 international stars, $250,000 prize pool    On Sport to broadcast Pan Arab Golf Championship for Juniors and Ladies in Egypt    Golf Festival in Cairo to mark Arab Golf Federation's 50th anniversary    Germany among EU's priciest labour markets – official data    Paris Olympic gold '24 medals hit record value    A minute of silence for Egyptian sports    Russia says it's in sync with US, China, Pakistan on Taliban    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Warning against use of 14 blood pressure drugs in Egypt
Published in Ahram Online on 26 - 07 - 2018

Egypt's consumer protection agency issued a warning in cooperation with the Ministry of Health, cautioning citizens against using 14 types of blood pressure drug, since they contain an ingredient that may cause cancer, according to a statement by the consumer protection agency.
Head of the consumer agency Rady Abdel Moaty said that the Egyptian Pharmacists Syndicate had previously issued a warning to all doctors against using any of the mentioned drugs.
The 14 drugs have been assessed as containing an excessive dosage of the active ingredient in "valsartan," which is known to be a generic agent used to treat high blood pressure and heart failure.
The substance used in valsartan is normally only used in limited proportions.
Valesartan, manufactured by a Chinese company, has been produced with higher than normal proportions of the substance according to the European Medicines Agency (EMA), causing an impurity in 14 blood pressure drugs which pose a potential cancer risk.
EMA is an agency of the European Union responsible for the scientific evaluation, supervision and safety monitoring of medicines.
According to an earlier notice issued by the Egyptian Health Ministry the 14 drugs are named as follows:
1. Valsarcard 80mg tab

5. Pressthioval tab

8. Disartan 80mg cap

12. Amilo Plus tab

2. Valsarcard Comb 80/12.5mg tab

6. Zarlodip tab

9. Disartan Co 80mg cap

13. Blokatens 5/160mg tab

3. Valsarcard Comb 160/12.5mg tab

7. Alkapress Plus 5/160mg F.C. tab

10. Disartan 160mg cap

14. Blokatens 10/160mg tab

4. Elimolivan 5/160mg tab

11. Disartan Co 160mg cap



Abdel Moaty says that the consumer protection authority has contacted all representatives of the pharmaceutical companies producing these drugs, instructing them to withdraw all of them from pharmacies immediately.
He stressed that the system would take the necessary action in cooperation with other regulatory bodies to ensure that companies would comply with the withdrawal of the drugs.
He pointed out that consumer protection campaigns will increase during the coming period to control the markets and ensure the safety of citizens.


Clic here to read the story from its source.